Bone Effects of Anti-Cancer Treatments in 2024.
Saved in:
| Title: | Bone Effects of Anti-Cancer Treatments in 2024. |
|---|---|
| Authors: | Teissonnière M; Pharmacie, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Point M; INSERM UMR1033-LYOS, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France., Biver E; Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Hadji P; Frankfurt Center of Bone Health & Philipps University of Marburg, Frankfurt, Germany., Bonnelye E; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France., Ebeling PR; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, 3168, Australia., Kendler D; Department of Medicine (Endocrinology), University of British Columbia, Vancouver, Canada., de Villiers T; Department Gynaecology, Stellenbosch University, Cape Town, South Africa., Holzer G; Medical University of Vienna, Vienna, Austria., Body JJ; Department of Medicine, CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium., Fuleihan GEH; Calcium Metabolism and Osteoporosis Program WHO Center for Metabolic Bone Disorders, American University of Beirut, Beirut, Lebanon., Brandi ML; FIRMO Foundation, Florence and University Vita-Salute San Raffaele, Milan, Italy., Rizzoli R; Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Confavreux CB; INSERM UMR1033-LYOS, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France. cyrille.confavreux@chu-lyon.fr.; Rheumatology Department, Bone Metastasis Expert Center (CEMOS), Hospices Civils of Lyon Cancer Institute (IC-HCL), Hôpital Lyon Sud, Pierre-Bénite, France. cyrille.confavreux@chu-lyon.fr.; Centre Expert Des Métastases Osseuses (CEMOS), Service de Rhumatologie Sud, Hôpital Lyon Sud, 165 chemin du Grand Revoyet, 69310, Pierre Bénite, France. cyrille.confavreux@chu-lyon.fr. |
| Source: | Calcified tissue international [Calcif Tissue Int] 2025 Mar 27; Vol. 116 (1), pp. 54. Date of Electronic Publication: 2025 Mar 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0827 (Electronic) Linking ISSN: 0171967X NLM ISO Abbreviation: Calcif Tissue Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40146323 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bone Effects of Anti-Cancer Treatments in 2024. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Teissonnière+M%22">Teissonnière M</searchLink>; Pharmacie, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Point+M%22">Point M</searchLink>; INSERM UMR1033-LYOS, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Biver+E%22">Biver E</searchLink>; Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hadji+P%22">Hadji P</searchLink>; Frankfurt Center of Bone Health & Philipps University of Marburg, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Bonnelye+E%22">Bonnelye E</searchLink>; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.<br /><searchLink fieldCode="AU" term="%22Ebeling+PR%22">Ebeling PR</searchLink>; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, 3168, Australia.<br /><searchLink fieldCode="AU" term="%22Kendler+D%22">Kendler D</searchLink>; Department of Medicine (Endocrinology), University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22de+Villiers+T%22">de Villiers T</searchLink>; Department Gynaecology, Stellenbosch University, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Holzer+G%22">Holzer G</searchLink>; Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Body+JJ%22">Body JJ</searchLink>; Department of Medicine, CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Fuleihan+GEH%22">Fuleihan GEH</searchLink>; Calcium Metabolism and Osteoporosis Program WHO Center for Metabolic Bone Disorders, American University of Beirut, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Brandi+ML%22">Brandi ML</searchLink>; FIRMO Foundation, Florence and University Vita-Salute San Raffaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Rizzoli+R%22">Rizzoli R</searchLink>; Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Confavreux+CB%22">Confavreux CB</searchLink>; INSERM UMR1033-LYOS, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France. cyrille.confavreux@chu-lyon.fr.; Rheumatology Department, Bone Metastasis Expert Center (CEMOS), Hospices Civils of Lyon Cancer Institute (IC-HCL), Hôpital Lyon Sud, Pierre-Bénite, France. cyrille.confavreux@chu-lyon.fr.; Centre Expert Des Métastases Osseuses (CEMOS), Service de Rhumatologie Sud, Hôpital Lyon Sud, 165 chemin du Grand Revoyet, 69310, Pierre Bénite, France. cyrille.confavreux@chu-lyon.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227905481%22">Calcified tissue international</searchLink> [Calcif Tissue Int] 2025 Mar 27; Vol. 116 (1), pp. 54. <i>Date of Electronic Publication: </i>2025 Mar 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7905481 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220171967X%22">0171967X </searchLink><i>NLM ISO Abbreviation: </i>Calcif Tissue Int <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40146323 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00223-025-01362-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 54 Titles: – TitleFull: Bone Effects of Anti-Cancer Treatments in 2024. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Teissonnière M – PersonEntity: Name: NameFull: Point M – PersonEntity: Name: NameFull: Biver E – PersonEntity: Name: NameFull: Hadji P – PersonEntity: Name: NameFull: Bonnelye E – PersonEntity: Name: NameFull: Ebeling PR – PersonEntity: Name: NameFull: Kendler D – PersonEntity: Name: NameFull: de Villiers T – PersonEntity: Name: NameFull: Holzer G – PersonEntity: Name: NameFull: Body JJ – PersonEntity: Name: NameFull: Fuleihan GEH – PersonEntity: Name: NameFull: Brandi ML – PersonEntity: Name: NameFull: Rizzoli R – PersonEntity: Name: NameFull: Confavreux CB IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 03 Text: 2025 Mar 27 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1432-0827 Numbering: – Type: volume Value: 116 – Type: issue Value: 1 Titles: – TitleFull: Calcified tissue international Type: main |
| ResultId | 1 |